SHENZHEN, May 7, 2019 – MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, and Genoks, a Turkish company committed to providing genetic sequencing platforms and kits in Turkey, today jointly announced that they have entered an exclusive collaborative agreement on Whole Exome Sequencing tests, which will be performed on the MGISEQ-2000 platform in Genoks Genetic Disease Diagnostic Center.
Under the partnership, Genoks will offer its regional knowledge and distribution network, and MGI will provide its genomic platform as well as bioinformatics expertise. The combination of the two organizations’ advantages will help to efficiently detect genetic abnormalities and improve human health in Turkey and other European countries.
Mr. Eren AKDENIZ, Managing Partner of Genoks, said, “Our shared mission is to leverage genomics expertise in order to advance life science research and improve human health for the benefit of mankind.” Genoks Chairman, Mr. Ozden BOSTAN, is committed to this goal and long term collaboration with MGI.
Mr. Duncan Yu, President of MGI, said, “MGI’s advanced technology enables high-throughput next generation sequencing to support life science research, medicine and healthcare. We are delighted to collaborate with Genoks to benefit Turkish customers in the field with MGI sequencing platforms. We expect our joint efforts could yield more achievements to significantly promote Turkish health in the near future.”
MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, is committed to enabling effective and affordable healthcare solutions for all. Based on its proprietary technology, MGI produces sequencing devices, equipment, consumables and reagents to support life science research, medicine and healthcare. MGI’s multi-omics platforms include genetic sequencing, mass spectrometry and medical imaging. Providing real-time, comprehensive, life-long solutions, its mission is to develop and promote advanced life science tools for future healthcare.
Genoks began its activities as an R&D laboratory in 2008 and has done many scientific researches on national and international platforms. Genoks and BGI Genomics (sister company of MGI) did technology transfer and running NIPT tests for the first time in Turkey using Next Generation Sequencing Technology. Genoks aims to provide full technical and strategic support to both private and public health institutes to expand the clinical genetic testing market, utilizing their technology background and effectiveness in neighboring countries. Genoks aims to grow in the short term with the investments in hospitals and institutions which seek support in the genetic field. www.genoks.com.tr
MGI Tech Co., Ltd.
Building 11, Beishan Industrial Zone, Yantian District
Genoks Genetic Diseases Diagnostic Center
Aziziye Mahallesi, Cinnah Caddesi, No: 64/B
Kristi Heim, Director of Communications, MGI